中医药研究论丛

202.6 中药配伍的禁忌:十八反与十九畏应用探讨

 

中药配伍的禁忌:十八反与十九畏应用探讨
Traditional Chinese Medicine Compatibility Taboo : Application Discussion of the Eighteen Toxic Interactions and the Nineteen Counteracting Interactions
吴柏锋1*
1 台北医学大学附设医院传统医学科,台北,台湾
【摘要】
关於中药配伍的禁忌,本文从《神农本草经》的七情配伍为起点,根据历史文献的记载与演进,了解十八反与十九畏论述形成的背景与意义。而且本文整理了现代实验研究成果,从化学成分、药理与毒理的角度探讨这些配伍禁忌的合理性。除此之外,更结合古代文献记录与各医家的用药经验加入讨论,帮助我们更好理解十八反与十九畏并非绝对禁忌,只是临床治疗还需根据病情病机条件谨慎运用。
【关键词】
十八反、十九畏、配伍禁忌、相恶
 
Bo-Feng Wu1*
1Department of Chinese Medicine, Taipei Medical University Hospital, Taipei, Taiwan
【Summary】
About Traditional Chinese Medicine compatibility taboo, this article stated from the seven prescription compatibilitys of “Shennong’s compendium of materia medica”, and with the records and development of the historical literatures, we could understand the background and significance of the eighteen toxic interactions and the nineteen counteracting interactions theory formation. With the collections of modern experimental research results, this article discussed the rationality of these compatibility taboo according to the conception of chemical compositions, pharmacology and toxicology. In addition, this discussion combined with the ancient literature records and the prescription experience of physicians could help us realize that the eighteen toxic interactions and the nineteen counteracting interactions theory is not an absolutely taboo. But in clinic al treatment, the prescription compatibility application of physicians must accord to the condition of pathogenesis and be cautious.
Keywords: The eighteen toxic interactions, The nineteen counteracting interactions, Compatibility taboo, The eliminating interactions